Loading…

Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance

Aims/hypothesis Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB 1 ) receptors in the liver and in epididymal vs subcutaneous WA...

Full description

Saved in:
Bibliographic Details
Published in:Diabetologia 2011-11, Vol.54 (11), p.2900-2910
Main Authors: Bartelt, A., Orlando, P., Mele, C., Ligresti, A., Toedter, K., Scheja, L., Heeren, J., Di Marzo, V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953
cites cdi_FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953
container_end_page 2910
container_issue 11
container_start_page 2900
container_title Diabetologia
container_volume 54
creator Bartelt, A.
Orlando, P.
Mele, C.
Ligresti, A.
Toedter, K.
Scheja, L.
Heeren, J.
Di Marzo, V.
description Aims/hypothesis Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB 1 ) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance. Methods We investigated, in Apoe −/− and wild-type (WT) mice, the effect of a high-fat diet (HFD) on: (1) subcutaneous and epididymal WAT accumulation, liver triacylglycerols, phospholipid-esterified fatty acids, inflammatory markers in WAT and liver, and insulin resistance; and (2) endocannabinoid levels, and the gene expression levels of the Cb 1 receptor and endocannabinoid metabolic enzymes in liver and WAT. Results After a 16 week HFD, Apoe −/− mice exhibited lower body weight, WAT accumulation and fasting leptin, glucose and insulin levels, and higher hepatic steatosis, than WT mice. Glucose clearance and insulin-mediated glucose disposal following the HFD were slower in WT than Apoe −/− mice, which exhibited higher levels of mRNA encoding inflammatory markers (tumour necrosis factor-α [TNF-α], monocyte chemoattractant protein-1 [MCP-1], cluster of differentiation 68 [CD68] and EGF-like module-containing mucin-like hormone receptor-like 1 [EMR1]) in the liver, but lower levels in epididymal WAT. HFD-induced elevation of endocannabinoid levels in the liver or epididymal WAT was higher or lower, respectively, in Apoe −/− mice, whereas HFD-induced decrease of subcutaneous WAT endocannabinoid and CB 1 receptor levels was significantly less marked. Alterations in endocannabinoid levels reflected changes in endocannabinoid catabolic enzymes in WAT, or the availability of phospholipid precursors in the liver. Conclusions/interpretation Liver and adipose tissue endocannabinoid tone following an HFD is altered on Apoe deletion and strongly associated with inflammation, insulin resistance and hepatic steatosis, or lack thereof.
doi_str_mv 10.1007/s00125-011-2274-6
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s00125_011_2274_6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21847582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953</originalsourceid><addsrcrecordid>eNp9kE1uFDEQhS1ERIbAAdggb9hhYru73W52o4g_KVI2ILFrVftnxlG33bI9SNyANSfgbJwkNUyAXWRZLrnee6X6CHkh-BvBeX9ZOBeyY1wIJmXfMvWIbETbSMZbqR-TzbHNhFZfz8nTUm45503XqifkXArd9p2WG_JrO1eXnaUu2mQgRphCTMHSEnYR5jnEHQWPEgp0H3Z75qFSG1ylIdLtmtzvHz8v8dIlGPeWZje7bxCNozVRsGFNBctQysGhwc-wLFBDiq_p3q1YGVqqg5pKKBSiRU054EzMwZ96DHpGzjzMxT2_fy_Il_fvPl99ZNc3Hz5dba-ZaYWqTIPRvpdW91abySOepvGTV6CmCRo-uJ47PApEB5xboTsBprd88AZ7Q9dcEHHKNTmVkp0f1xwWyN9Hwccj7fFEe0Ta45H2qNDz8uRZD9Pi7D_HX7woeHUvgGJg9hk3CuW_rlWDHP4MlyddwVbcuTzepkNG_uWB6XcjCZz_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance</title><source>Springer Link</source><creator>Bartelt, A. ; Orlando, P. ; Mele, C. ; Ligresti, A. ; Toedter, K. ; Scheja, L. ; Heeren, J. ; Di Marzo, V.</creator><creatorcontrib>Bartelt, A. ; Orlando, P. ; Mele, C. ; Ligresti, A. ; Toedter, K. ; Scheja, L. ; Heeren, J. ; Di Marzo, V.</creatorcontrib><description>Aims/hypothesis Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB 1 ) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance. Methods We investigated, in Apoe −/− and wild-type (WT) mice, the effect of a high-fat diet (HFD) on: (1) subcutaneous and epididymal WAT accumulation, liver triacylglycerols, phospholipid-esterified fatty acids, inflammatory markers in WAT and liver, and insulin resistance; and (2) endocannabinoid levels, and the gene expression levels of the Cb 1 receptor and endocannabinoid metabolic enzymes in liver and WAT. Results After a 16 week HFD, Apoe −/− mice exhibited lower body weight, WAT accumulation and fasting leptin, glucose and insulin levels, and higher hepatic steatosis, than WT mice. Glucose clearance and insulin-mediated glucose disposal following the HFD were slower in WT than Apoe −/− mice, which exhibited higher levels of mRNA encoding inflammatory markers (tumour necrosis factor-α [TNF-α], monocyte chemoattractant protein-1 [MCP-1], cluster of differentiation 68 [CD68] and EGF-like module-containing mucin-like hormone receptor-like 1 [EMR1]) in the liver, but lower levels in epididymal WAT. HFD-induced elevation of endocannabinoid levels in the liver or epididymal WAT was higher or lower, respectively, in Apoe −/− mice, whereas HFD-induced decrease of subcutaneous WAT endocannabinoid and CB 1 receptor levels was significantly less marked. Alterations in endocannabinoid levels reflected changes in endocannabinoid catabolic enzymes in WAT, or the availability of phospholipid precursors in the liver. Conclusions/interpretation Liver and adipose tissue endocannabinoid tone following an HFD is altered on Apoe deletion and strongly associated with inflammation, insulin resistance and hepatic steatosis, or lack thereof.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-011-2274-6</identifier><identifier>PMID: 21847582</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adipose Tissue, White - immunology ; Adipose Tissue, White - metabolism ; Animals ; Apolipoproteins E - genetics ; Apolipoproteins E - physiology ; Biological and medical sciences ; Cannabinoid Receptor Modulators - metabolism ; Cells, Cultured ; Diabetes. Impaired glucose tolerance ; Dietary Fats - adverse effects ; Endocannabinoids ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Fatty Liver - immunology ; Fatty Liver - metabolism ; Fatty Liver - pathology ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Regulation ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Human Physiology ; Inflammation Mediators - metabolism ; Insulin Resistance ; Internal Medicine ; Lipid Metabolism ; Liver - metabolism ; Liver - pathology ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Other diseases. Semiology ; Panniculitis - immunology ; Panniculitis - metabolism ; Receptor, Cannabinoid, CB1 - genetics ; Receptor, Cannabinoid, CB1 - metabolism ; RNA, Messenger - metabolism ; Signal Transduction ; Subcutaneous Fat - immunology ; Subcutaneous Fat - metabolism</subject><ispartof>Diabetologia, 2011-11, Vol.54 (11), p.2900-2910</ispartof><rights>Springer-Verlag 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953</citedby><cites>FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24692995$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21847582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bartelt, A.</creatorcontrib><creatorcontrib>Orlando, P.</creatorcontrib><creatorcontrib>Mele, C.</creatorcontrib><creatorcontrib>Ligresti, A.</creatorcontrib><creatorcontrib>Toedter, K.</creatorcontrib><creatorcontrib>Scheja, L.</creatorcontrib><creatorcontrib>Heeren, J.</creatorcontrib><creatorcontrib>Di Marzo, V.</creatorcontrib><title>Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB 1 ) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance. Methods We investigated, in Apoe −/− and wild-type (WT) mice, the effect of a high-fat diet (HFD) on: (1) subcutaneous and epididymal WAT accumulation, liver triacylglycerols, phospholipid-esterified fatty acids, inflammatory markers in WAT and liver, and insulin resistance; and (2) endocannabinoid levels, and the gene expression levels of the Cb 1 receptor and endocannabinoid metabolic enzymes in liver and WAT. Results After a 16 week HFD, Apoe −/− mice exhibited lower body weight, WAT accumulation and fasting leptin, glucose and insulin levels, and higher hepatic steatosis, than WT mice. Glucose clearance and insulin-mediated glucose disposal following the HFD were slower in WT than Apoe −/− mice, which exhibited higher levels of mRNA encoding inflammatory markers (tumour necrosis factor-α [TNF-α], monocyte chemoattractant protein-1 [MCP-1], cluster of differentiation 68 [CD68] and EGF-like module-containing mucin-like hormone receptor-like 1 [EMR1]) in the liver, but lower levels in epididymal WAT. HFD-induced elevation of endocannabinoid levels in the liver or epididymal WAT was higher or lower, respectively, in Apoe −/− mice, whereas HFD-induced decrease of subcutaneous WAT endocannabinoid and CB 1 receptor levels was significantly less marked. Alterations in endocannabinoid levels reflected changes in endocannabinoid catabolic enzymes in WAT, or the availability of phospholipid precursors in the liver. Conclusions/interpretation Liver and adipose tissue endocannabinoid tone following an HFD is altered on Apoe deletion and strongly associated with inflammation, insulin resistance and hepatic steatosis, or lack thereof.</description><subject>Adipose Tissue, White - immunology</subject><subject>Adipose Tissue, White - metabolism</subject><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - physiology</subject><subject>Biological and medical sciences</subject><subject>Cannabinoid Receptor Modulators - metabolism</subject><subject>Cells, Cultured</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Dietary Fats - adverse effects</subject><subject>Endocannabinoids</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Fatty Liver - immunology</subject><subject>Fatty Liver - metabolism</subject><subject>Fatty Liver - pathology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Regulation</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Human Physiology</subject><subject>Inflammation Mediators - metabolism</subject><subject>Insulin Resistance</subject><subject>Internal Medicine</subject><subject>Lipid Metabolism</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Other diseases. Semiology</subject><subject>Panniculitis - immunology</subject><subject>Panniculitis - metabolism</subject><subject>Receptor, Cannabinoid, CB1 - genetics</subject><subject>Receptor, Cannabinoid, CB1 - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal Transduction</subject><subject>Subcutaneous Fat - immunology</subject><subject>Subcutaneous Fat - metabolism</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kE1uFDEQhS1ERIbAAdggb9hhYru73W52o4g_KVI2ILFrVftnxlG33bI9SNyANSfgbJwkNUyAXWRZLrnee6X6CHkh-BvBeX9ZOBeyY1wIJmXfMvWIbETbSMZbqR-TzbHNhFZfz8nTUm45503XqifkXArd9p2WG_JrO1eXnaUu2mQgRphCTMHSEnYR5jnEHQWPEgp0H3Z75qFSG1ylIdLtmtzvHz8v8dIlGPeWZje7bxCNozVRsGFNBctQysGhwc-wLFBDiq_p3q1YGVqqg5pKKBSiRU054EzMwZ96DHpGzjzMxT2_fy_Il_fvPl99ZNc3Hz5dba-ZaYWqTIPRvpdW91abySOepvGTV6CmCRo-uJ47PApEB5xboTsBprd88AZ7Q9dcEHHKNTmVkp0f1xwWyN9Hwccj7fFEe0Ta45H2qNDz8uRZD9Pi7D_HX7woeHUvgGJg9hk3CuW_rlWDHP4MlyddwVbcuTzepkNG_uWB6XcjCZz_</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Bartelt, A.</creator><creator>Orlando, P.</creator><creator>Mele, C.</creator><creator>Ligresti, A.</creator><creator>Toedter, K.</creator><creator>Scheja, L.</creator><creator>Heeren, J.</creator><creator>Di Marzo, V.</creator><general>Springer-Verlag</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20111101</creationdate><title>Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance</title><author>Bartelt, A. ; Orlando, P. ; Mele, C. ; Ligresti, A. ; Toedter, K. ; Scheja, L. ; Heeren, J. ; Di Marzo, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adipose Tissue, White - immunology</topic><topic>Adipose Tissue, White - metabolism</topic><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - physiology</topic><topic>Biological and medical sciences</topic><topic>Cannabinoid Receptor Modulators - metabolism</topic><topic>Cells, Cultured</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Dietary Fats - adverse effects</topic><topic>Endocannabinoids</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Fatty Liver - immunology</topic><topic>Fatty Liver - metabolism</topic><topic>Fatty Liver - pathology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Regulation</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Human Physiology</topic><topic>Inflammation Mediators - metabolism</topic><topic>Insulin Resistance</topic><topic>Internal Medicine</topic><topic>Lipid Metabolism</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Other diseases. Semiology</topic><topic>Panniculitis - immunology</topic><topic>Panniculitis - metabolism</topic><topic>Receptor, Cannabinoid, CB1 - genetics</topic><topic>Receptor, Cannabinoid, CB1 - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal Transduction</topic><topic>Subcutaneous Fat - immunology</topic><topic>Subcutaneous Fat - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bartelt, A.</creatorcontrib><creatorcontrib>Orlando, P.</creatorcontrib><creatorcontrib>Mele, C.</creatorcontrib><creatorcontrib>Ligresti, A.</creatorcontrib><creatorcontrib>Toedter, K.</creatorcontrib><creatorcontrib>Scheja, L.</creatorcontrib><creatorcontrib>Heeren, J.</creatorcontrib><creatorcontrib>Di Marzo, V.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bartelt, A.</au><au>Orlando, P.</au><au>Mele, C.</au><au>Ligresti, A.</au><au>Toedter, K.</au><au>Scheja, L.</au><au>Heeren, J.</au><au>Di Marzo, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>54</volume><issue>11</issue><spage>2900</spage><epage>2910</epage><pages>2900-2910</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB 1 ) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance. Methods We investigated, in Apoe −/− and wild-type (WT) mice, the effect of a high-fat diet (HFD) on: (1) subcutaneous and epididymal WAT accumulation, liver triacylglycerols, phospholipid-esterified fatty acids, inflammatory markers in WAT and liver, and insulin resistance; and (2) endocannabinoid levels, and the gene expression levels of the Cb 1 receptor and endocannabinoid metabolic enzymes in liver and WAT. Results After a 16 week HFD, Apoe −/− mice exhibited lower body weight, WAT accumulation and fasting leptin, glucose and insulin levels, and higher hepatic steatosis, than WT mice. Glucose clearance and insulin-mediated glucose disposal following the HFD were slower in WT than Apoe −/− mice, which exhibited higher levels of mRNA encoding inflammatory markers (tumour necrosis factor-α [TNF-α], monocyte chemoattractant protein-1 [MCP-1], cluster of differentiation 68 [CD68] and EGF-like module-containing mucin-like hormone receptor-like 1 [EMR1]) in the liver, but lower levels in epididymal WAT. HFD-induced elevation of endocannabinoid levels in the liver or epididymal WAT was higher or lower, respectively, in Apoe −/− mice, whereas HFD-induced decrease of subcutaneous WAT endocannabinoid and CB 1 receptor levels was significantly less marked. Alterations in endocannabinoid levels reflected changes in endocannabinoid catabolic enzymes in WAT, or the availability of phospholipid precursors in the liver. Conclusions/interpretation Liver and adipose tissue endocannabinoid tone following an HFD is altered on Apoe deletion and strongly associated with inflammation, insulin resistance and hepatic steatosis, or lack thereof.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>21847582</pmid><doi>10.1007/s00125-011-2274-6</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2011-11, Vol.54 (11), p.2900-2910
issn 0012-186X
1432-0428
language eng
recordid cdi_crossref_primary_10_1007_s00125_011_2274_6
source Springer Link
subjects Adipose Tissue, White - immunology
Adipose Tissue, White - metabolism
Animals
Apolipoproteins E - genetics
Apolipoproteins E - physiology
Biological and medical sciences
Cannabinoid Receptor Modulators - metabolism
Cells, Cultured
Diabetes. Impaired glucose tolerance
Dietary Fats - adverse effects
Endocannabinoids
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Fatty Liver - immunology
Fatty Liver - metabolism
Fatty Liver - pathology
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Regulation
Hepatocytes - metabolism
Hepatocytes - pathology
Human Physiology
Inflammation Mediators - metabolism
Insulin Resistance
Internal Medicine
Lipid Metabolism
Liver - metabolism
Liver - pathology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Medicine
Medicine & Public Health
Metabolic Diseases
Mice
Mice, Inbred C57BL
Mice, Knockout
Other diseases. Semiology
Panniculitis - immunology
Panniculitis - metabolism
Receptor, Cannabinoid, CB1 - genetics
Receptor, Cannabinoid, CB1 - metabolism
RNA, Messenger - metabolism
Signal Transduction
Subcutaneous Fat - immunology
Subcutaneous Fat - metabolism
title Altered endocannabinoid signalling after a high-fat diet in Apoe−/− mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A11%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20endocannabinoid%20signalling%20after%20a%20high-fat%20diet%20in%20Apoe%E2%88%92/%E2%88%92%20mice:%20relevance%20to%20adipose%20tissue%20inflammation,%20hepatic%20steatosis%20and%20insulin%20resistance&rft.jtitle=Diabetologia&rft.au=Bartelt,%20A.&rft.date=2011-11-01&rft.volume=54&rft.issue=11&rft.spage=2900&rft.epage=2910&rft.pages=2900-2910&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-011-2274-6&rft_dat=%3Cpubmed_cross%3E21847582%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-8ac8f72d87d8cbf10033fbf6a6bba309e70e0e06a15a00d1851ac7d09fc9e7953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/21847582&rfr_iscdi=true